CurveBeam AI secures China ODI approval for $10M strategic investment
CurveBeam AI (ASX:CVB) has received formal approval under China's outbound direct investment framework for a strategic equity investment from Shandong WeiYing Intelligent Medical Technology.









-640x360.png&w=3840&q=75)

